Bimatoprost Ophthalmic Solution and Travoprost
Determining the interaction of Bimatoprost Ophthalmic Solution and Travoprost and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using bimatoprost ophthalmic together with travoprost ophthalmic may reduce the pressure-lowering effects of these medications in the eye. Talk to your doctor if you have any questions or concerns. You may need more frequent eye examinations to safely use these medications together. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Concurrent use of multiple prostaglandin analogs, as well as more frequent administration of a prostaglandin analog than recommended, may reduce the intraocular pressure (IOP) lowering effects of these agents. A case series of 3 patients described IOP elevations of 6 to 23 mmHg two to five weeks after bimatoprost was added to a latanoprost regimen. The precise mechanism of interaction has not been established, although the combination exceeded the dose-response curve, which may have led to the paradoxical effects on IOP. Other factors such as disease state and patient compliance may also have contributed. In a randomized clinical trial of 18 patients with non-advanced primary open angle glaucoma, mean IOP increased by 1.8 mmHg four weeks after the addition of bimatoprost to preexisting latanoprost treatment, but returned to baseline after discontinuation of bimatoprost.
MANAGEMENT: Concomitant administration of two or more prostaglandin analogs, or more frequent administration of a prostaglandin analog than approved by the manufacturers, is generally not recommended.
- Doi LM, Melo LA, Prata JA "Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomized clinical trial." Br J Ophthalmol 89 (2005): 547-9
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Herndon LW, Asrani SG, Williams GH, Challa P, Lee PP "Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost." Arch Ophthalmol 120 (2002): 847-9
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Xalatan (latanoprost ophthalmic)." Pharmacia and Upjohn, Kalamazoo, MI.
Generic Name: bimatoprost ophthalmic
Brand name: Lumigan
Synonyms: Bimatoprost, Bimatoprost ophthalmic
Generic Name: travoprost ophthalmic
Brand name: Travatan, Travatan Z
Synonyms: Travoprost ophthalmic
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bimatoprost Ophthalmic Solution-Travoprost ophthalmic
- Bimatoprost Ophthalmic Solution-Travoprost Ophthalmic Solution
- Bimatoprost Ophthalmic Solution-Trazodone
- Bimatoprost Ophthalmic Solution-Trazodone Extended-Release Tablets
- Bimatoprost Ophthalmic Solution-Trazodone Hydrochloride
- Bimatoprost Ophthalmic Solution-Trazodone Oral
- Travoprost-Bimatoprost topical ophthalmic
- Travoprost-Binimetinib
- Travoprost-Binora Topical
- Travoprost-Binosto
- Travoprost-Bio Glo
- Travoprost-Bio-Cef